Scripps

La Jolla, California 92037

1 studies enrolling now · 11 studies all time

What they study most

Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Extrahepatic, Cholangiocarcinoma, Intrahepatic, Class I or II Indication for Implantation of a Single Chamber Ventricular Pacemaker According to ACC/AHA/HRS 2001 Guidelines and Any National Guidelines, Gallbladder Adenocarcinoma, Hepatitis, Hepatitis C, Liver Transplant, Myocardial Infarction, Patients Undergoing High Risk PCI., Percutaneous Large Hole Vascular Closure, Postoperative Pain

Studies at this site

• Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH) — Recruiting now
• PerQseal® Clinical Study — Running, not enrolling
• OCS Liver PROTECT Continued Access Protocol — Completed
• Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration — Stopped early
• HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network — Completed
• OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study — Completed
• OsseoFix™ Spinal Fracture Reduction System in Treating Spinal Compression Fracture — Stopped early
• Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma — Stopped early
• Micra Transcatheter Pacing Study — Completed
• A Phase 3 Study to Evaluate the Safety and Efficacy of SKY0402 in Subjects Undergoing Total Knee Arthroplasty — Completed
• PROTECT I, A Prospective Feasibility Trial Investigating the Use of IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI — Completed